Bank of Nova Scotia grew its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 87.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 902,217 shares of the company’s stock after purchasing an additional 420,734 shares during the quarter. Bank of Nova Scotia’s holdings in Procter & Gamble were worth $143,741,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in PG. Nova Wealth Management Inc. bought a new stake in Procter & Gamble in the first quarter valued at $26,000. Signature Resources Capital Management LLC grew its position in shares of Procter & Gamble by 67.9% during the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares during the last quarter. Quarry LP acquired a new stake in shares of Procter & Gamble in the 1st quarter worth about $33,000. Mid American Wealth Advisory Group Inc. bought a new stake in Procter & Gamble in the 2nd quarter valued at about $34,000. Finally, RMG Wealth Management LLC acquired a new position in Procter & Gamble during the 2nd quarter valued at about $37,000. Institutional investors own 65.77% of the company’s stock.
Insider Activity at Procter & Gamble
In other news, CEO Jennifer L. Davis sold 3,227 shares of the company’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the sale, the chief executive officer directly owned 61,764 shares of the company’s stock, valued at $9,402,333.72. This represents a 4.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Gary A. Coombe sold 3,535 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $538,133.05. Following the completion of the transaction, the chief executive officer directly owned 34,816 shares in the company, valued at $5,300,039.68. This represents a 9.22% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 30,308 shares of company stock valued at $4,611,852 over the last ninety days. Company insiders own 0.20% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. The business had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Friday, October 24th were paid a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is currently 61.75%.
Analyst Ratings Changes
Several equities research analysts have commented on PG shares. Raymond James Financial dropped their price target on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Berenberg Bank increased their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Monday, December 1st. Wells Fargo & Company reduced their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. Finally, Morgan Stanley set a $175.00 price target on Procter & Gamble in a research note on Monday, October 27th. Twelve research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $171.53.
View Our Latest Report on Procter & Gamble
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
- Five stocks we like better than Procter & Gamble
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Five Below and Dollar Tree Earnings Signal a Shopper Shift
- Why Are Stock Sectors Important to Successful Investing?
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
